Comparative analysis of adiposity indices for predicting 2-year hypertension incidence in children and adolescents: a retrospective study

比较肥胖指数对预测儿童和青少年2年高血压发病率的影响:一项回顾性研究

阅读:2

Abstract

BACKGROUND: The aim of this study was to systemically examine the concomitant impact of adiposity indices on hypertension in children and adolescents. METHODS: A community-based cohort study conducted by the China Health and Nutrition Survey (CHNS) 2009-2011 included 262 children and adolescents aged 7-17 years. Anthropometric and lipid profiles were analyzed for hypertension risk using logistic and cross-lagged models. RESULTS: Among the 227 participants (mean age, 16.5 years), 147 (53.9%) were boys. Over 2 years, 26.4% of patients developed hypertension, 5.3% had elevated systolic blood pressure (SBP), and 25.6% had elevated diastolic blood pressure (DBP). After adjusting for covariates, higher body mass index (BMI), waist circumference (WC), hip circumference (HC), triceps skinfold thickness (TST), and body roundness index (BRI) were associated with an increased risk of hypertension. Incorporating these measures into a BP-based model improved the area under the curve (AUC) for hypertension prediction from 0.551 to 0.670. A longitudinal relationship was observed between adiposity indices and hypertension symptoms. CONCLUSIONS: This study suggests that anthropometric parameters are superior to blood lipid indicators in predicting the occurrence of hypertension in children. Abdominal obesity, as indicated by WC, HC, and BRI, accounts for a significant proportion of the risk of hypertension, particularly in children aged 7-12 years. IMPACT: Anthropometric parameters are superior to blood lipid indicators in predicting the occurrence of hypertension in children. Abdominal obesity, as indicated by WC, and HC, accounts for a significant proportion of the risk of hypertension, particularly in children aged 7-12 years. The indices of BMI-WC-HC or BRI-HC appear to be the most promising indices for prevention and risk stratification for pediatric hypertension.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。